======= MYF6 ======= == Gene Information == * **Official Symbol**: MYF6 * **Official Name**: myogenic factor 6 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4618|4618]] * **UniProt**: [[https://www.uniprot.org/uniprot/P23409|P23409]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MYF6&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MYF6|Open PubMed]] * **OMIM**: [[https://omim.org/entry/159991|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a probable basic helix-loop-helix (bHLH) DNA binding protein involved in muscle differentiation. The encoded protein likely acts as a heterodimer with another bHLH protein. Defects in this gene are a cause of autosomal dominant centronuclear myopathy (ADCNM). [provided by RefSeq, May 2010]. * **UniProt Summary**: Involved in muscle differentiation (myogenic factor). Induces fibroblasts to differentiate into myoblasts. Probable sequence specific DNA-binding protein. |HLH| |Basic| |positive regulation of skeletal muscle fiber development| |regulation of skeletal muscle fiber development| |muscle cell fate commitment| |positive regulation of myoblast fusion| |regulation of myoblast fusion| |positive regulation of myoblast differentiation| |positive regulation of skeletal muscle tissue development| |positive regulation of syncytium formation by plasma membrane fusion| |regulation of syncytium formation by plasma membrane fusion| |positive regulation of myotube differentiation| |skeletal muscle tissue regeneration| |regulation of skeletal muscle tissue development| |E-box binding| |skeletal muscle cell differentiation| |regulation of myoblast differentiation| |regulation of myotube differentiation| |positive regulation of striated muscle cell differentiation| |tissue regeneration| |somitogenesis| |positive regulation of striated muscle tissue development| |positive regulation of muscle organ development| |positive regulation of muscle tissue development| |RNA polymerase II transcription factor complex| |muscle tissue morphogenesis| |somite development| |muscle organ morphogenesis| |positive regulation of muscle cell differentiation| |segmentation| |regulation of striated muscle cell differentiation| |skeletal muscle tissue development| |regulation of striated muscle tissue development| |skeletal muscle organ development| |regulation of muscle tissue development| |regulation of muscle organ development| |regulation of muscle cell differentiation| |regeneration| |anterior/posterior pattern specification| |muscle cell differentiation| |cell fate commitment| |striated muscle tissue development| |muscle organ development| |muscle tissue development| |regionalization| |developmental growth| |growth| |pattern specification process| |DNA-binding transcription activator activity, RNA polymerase II-specific| |muscle structure development| |wound healing| |protein heterodimerization activity| |RNA polymerase II proximal promoter sequence-specific DNA binding| |positive regulation of cell development| |tissue morphogenesis| |response to wounding| |chordate embryonic development| |embryo development ending in birth or egg hatching| |DNA-binding transcription factor activity| |anatomical structure formation involved in morphogenesis| |regulation of cell development| |animal organ morphogenesis| |positive regulation of cell differentiation| |embryo development| |regulation of anatomical structure morphogenesis| |epithelium development| |negative regulation of transcription, DNA-templated| |positive regulation of cellular component organization| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |tissue development| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|-1.77| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8651 * **Expression level (log2 read counts)**: -7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}